EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Changes in the Transcriptome Profile of Human Hepatoma HepG2 Cells Exposed to Combined Sorafenib and Cannabis Treatment

Krittakarn Udomkritayachai, Theeraphat Thiamsuk, Takdanai Jarujamrat, Panaphas Kudikhong, Sira Raksakhom, Phitsamai Suphattana, Natthanan Khankham, Palapoom Thanawong, Supakit Khacha-Ananda iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27104342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Krittakarn Udomkritayachai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Sorafenib, Transcriptome, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis-derived compounds are increasingly used as adjuncts in cancer therapy due to their reported antiproliferative and pro-apoptotic effects. However, potential drug–herb interactions with standard anticancer agents—namely sorafenib—remain unclear. This study investigated the interaction between cannabis and sorafenib, together with transcriptomic alterations in human hepatoma HepG2 cells. Cell viability was assessed using the MTT assay, and drug interactions were evaluated using the Combenefit program. RNA sequencing was performed to characterize gene expression changes across treatment groups. Combination analysis demonstrated concentration-dependent synergistic effects at intermediate doses. Transcriptomic profiling revealed that the combination treatment induced a broader and more distinct set of differentially expressed genes compared with single treatments. Integrated enrichment analyses showed consistent activation of stress- and inflammation-related pathways, including tumor necrosis factor-α via nuclear factor-kappaB (TNF/NF-κB), mitogen-activated protein kinase (MAPK), janus kinase/signal transducers and activators of transcription (JAK–STAT), oxidative stress, and p53-mediated apoptosis, alongside suppression of metabolic and proliferative processes. While several pathways were shared across treatments, the combination group exhibited a more coordinated transcriptional response, including enrichment of integrated stress response, cytokine signaling, endoplasmic reticulum stress, and epigenetic regulation. These findings were supported by increased reactive oxygen species production and apoptosis, particularly in the combination group. Overall, cannabis may potentiate sorafenib activity through enhanced cellular stress and anti-proliferative signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibTranscriptomeLiver NeoplasmsCarcinoma, HepatocellularCannabisAntineoplastic AgentsHumansHep G2 CellsGene Expression ProfilingGene Expression Regulation, NeoplasticCell SurvivalApoptosisSignal TransductionDrug Synergism

Stichwörter der Autor:innen

cannabishepatocarcinoma cancer cellssorafenibtranscriptome

Substanzen

SorafenibAntineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Multidisciplinary and Interdisciplinary School, Chiang Mai University, Chiang Mai 50200, Thailand.

ORCID-Profile: Supakit Khacha-Ananda

Förderung

  • Faculty of Medicine, Chiang Mai University

Zitieren

APA

Udomkritayachai, K., Thiamsuk, T., Jarujamrat, T., Kudikhong, P., Raksakhom, S., Suphattana, P., Khankham, N., Thanawong, P., & Khacha-Ananda, S. (2026). Identification of Changes in the Transcriptome Profile of Human Hepatoma HepG2 Cells Exposed to Combined Sorafenib and Cannabis Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104342

Vancouver

Udomkritayachai K, Thiamsuk T, Jarujamrat T, Kudikhong P, Raksakhom S, Suphattana P, et al. Identification of Changes in the Transcriptome Profile of Human Hepatoma HepG2 Cells Exposed to Combined Sorafenib and Cannabis Treatment. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104342

BibTeX
@article{Udomkritayachai2026,
  author = {Udomkritayachai, Krittakarn and Thiamsuk, Theeraphat and Jarujamrat, Takdanai and Kudikhong, Panaphas and Raksakhom, Sira and Suphattana, Phitsamai and Khankham, Natthanan and Thanawong, Palapoom and Khacha-Ananda, Supakit},
  title = {Identification of Changes in the Transcriptome Profile of Human Hepatoma HepG2 Cells Exposed to Combined Sorafenib and Cannabis Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27104342}
}
Kostenlos starten →